Worldwide burden of cancer attributable to HPV by site, country and HPV type.
about
Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.Telomerase Induction in HPV Infection and Oncogenesis.The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.Human papillomavirus related oropharyngeal cancer.Trends in oral squamous cell carcinoma: Diagnosis for effective, evidence-based treatment 2017.Role of p16 testing in cervical cancer screening among HIV-infected womenExamining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines.Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.Therapeutic vaccines for high-risk HPV-associated diseases.Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.Combination of 247 genome-wide association studies reveals high cancer risk as a result of evolutionary adaptation.Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.9-Valent human papillomavirus vaccine: a review of the clinical development program.The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.Principles of vaccine potency assays.The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?Impacts of human papillomavirus vaccination for different populations: A modelling study.A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway.Human Papillomavirus Type 16 Integration Analysis by Real-time PCR Assay in Associated Cancers.Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.Oropharyngeal HPV infection: prevalence and sampling methods among HIV-infected men in South Africa.Comparative assessment of HPV, alcohol and tobacco etiological fractions in Algerian patients with laryngeal squamous cell carcinoma.Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.Human papillomavirus genome variants and head and neck cancers: a perspective.Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.Epidemiological science and cancer controlCervical cancer in Iran: integrative insights of epidemiological analysisEffect of human papillomavirus vaccination on sexual behaviour among young femalesNaturally Occurring Variations Modulate the Activity of the HPV33 Early Promoter and its Affinity for the E2 Transcription FactorHuman Papillomavirus in Head and Neck Squamous Cell Carcinomas in a South African CohortAwareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco
P2860
Q39415253-BE12002F-75D6-4D1F-AA8C-4DB96876E2A7Q39429557-C2F52E46-DF6F-44FA-9645-A066D92AB402Q39438439-FEFF3DB8-6935-42CB-A7C5-07E7291CD7FFQ40046826-9B4EC384-AEF0-4095-A4EA-7249926E7B58Q40152615-D390DFFB-D233-400E-B8B3-42B1DB0F7E6BQ41162769-4DFC097D-02E6-4834-BC4E-2CD30166294CQ41986617-61D5F46B-0A7B-4605-B659-BE89D73371D4Q42370741-CAB253DF-74B9-4195-8D54-9C7FA363C4D5Q45326416-188DAB08-2AB7-4DA1-B82C-DADDBCAFA7F7Q47104746-6985C9E1-1DE6-460D-9F9B-4AF675018BFFQ47105544-B9156CC4-571C-4AC4-B95E-54FAA55395ADQ47110234-2D797B36-CAA4-4842-98D9-3F03E1D4574EQ47255618-0A86CDDA-9858-458D-A30D-5A83A2FAC5FFQ47264132-7077AEA9-06EF-4552-AAF7-6D4C4DA5DE28Q47343132-12C880D9-FB12-4A96-8F42-C486C6A31BD4Q47439863-E6F370B9-999D-484B-93FF-2AA292C64C92Q49687633-205C2763-921A-43F0-B80F-14EA0726C1B1Q50042026-634C3DF8-A94B-4DB4-8E21-91FD790B11E9Q50047834-3656860C-0A55-47AB-BB44-34410EBF0906Q50133379-ADECC8C6-D63B-49F5-AD3E-FDF4AE7B5913Q51731914-EC4EB106-48BD-48BF-B67C-E83FC5CD47F3Q52560123-14102B9A-0393-4E42-9FD6-73D11F2CD434Q52617409-7E18E923-CE23-4D09-8B8C-0622AF59FDB4Q52659539-4BA28D16-56AE-4B5C-8D6D-70ADAD92047DQ53177082-F4BA11BB-05FA-4564-B2A7-9E3D4769C20DQ54210245-0E64810F-2AC2-44A1-AA3B-A681D42D4D9AQ54268214-4CF80282-38B2-47AE-96F3-8690671B5CB5Q54940415-F9E91E1B-414D-43DD-A303-342DB1E59BBBQ55008093-0A751E15-889C-4AE7-ADC5-4501E767A8D2Q55211458-B8DE07F8-F583-4DBD-93A0-65B17A69361BQ55239038-21CFF829-7E31-4CF5-9EAF-510B23A470FBQ55284319-1179A769-218D-4C61-B5D3-A1BC5AE4C8C8Q55293654-5C7D906B-D000-4651-B6CA-29128EAEEBDAQ55652233-BFB83CB7-B4D5-4873-8488-31E09546CF30Q57071077-609D06D5-7581-46FA-9E62-F430AB63824DQ57162663-9D180EE4-FFFA-4299-A83E-81AF5F7540CFQ57177804-0FF8DF19-8337-40B0-9752-843C6567DA1EQ57292425-1F6B54B1-E5DD-45AE-A872-CB7091320DB8Q58587244-AE5FA5C9-6F8E-439E-84B6-F462C6A5E412Q58713263-0AC212AF-263C-4B20-B20C-572F319C5547
P2860
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
@en
type
label
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
@en
prefLabel
Worldwide burden of cancer attributable to HPV by site, country and HPV type.
@en
P2860
P50
P356
P1476
Worldwide burden of cancer attributable to HPV by site, country and HPV type
@en
P2093
Jerome Vignat
P2860
P304
P356
10.1002/IJC.30716
P577
2017-06-08T00:00:00Z